https://www.selleckchem.com/products/MLN-2238.html
The median overall survival in the metastatic setting in our cohort was 51 months, which is consistent with previously published cases. Primary ovarian leiomyosarcoma is an extremely rare malignancy with a poor prognosis. This study is the largest case series of primary ovarian leiomyosarcoma published to date, providing clinically important information regarding survival and metastatic rate as well as treatment outcomes in the metastatic setting.Adenoid cystic carcinoma (ACC) of the Bartholins gland, first described by Klob in 1864, i
Like
Comment
Share
